Home > Annual Financials > SUDARSHAN PHARMA INDUSTRIES

SUDARSHAN PHARMA INDUSTRIES Financial Statement Analysis
[BOM: 543828]

The Revenues of SUDARSHAN PHARMA INDUSTRIES have increased by 8.95% YoY .
The Earnings Per Share (EPS) of SUDARSHAN PHARMA INDUSTRIES has decreased by -86.13 % YoY.
COMMUNITY POLL
for SUDARSHAN PHARMA INDUSTRIES
Please provide your vote to see the results

SUDARSHAN PHARMA INDUSTRIES Last 5 Annual Financial Results
[BOM: 543828]

ConsolidatedMar2025
Mar2024
Mar2023
Mar2022
Mar2021
Revenues ₹505 Cr₹464 Cr₹461 Cr₹357 Cr₹193 Cr
Expenses ₹465 Cr₹441 Cr₹447 Cr₹346 Cr₹186 Cr
Operating Profit (Excl OI) ₹40 Cr₹23 Cr₹15 Cr₹11 Cr₹7.16 Cr
Other Income ₹2.52 Cr₹2.61 Cr₹1.12 Cr₹0.46 Cr₹0.38 Cr
Interest ₹16 Cr₹8.95 Cr₹5.40 Cr₹3.38 Cr₹3.23 Cr
Depreciation ₹2.22 Cr₹1.24 Cr₹0.91 Cr₹0.87 Cr₹0.74 Cr
Profit Before Tax ₹22 Cr₹15 Cr₹9.50 Cr₹7.14 Cr₹3.58 Cr
Profit After Tax ₹16 Cr₹11 Cr₹7.04 Cr₹5.25 Cr₹2.67 Cr
Consolidated Net Profit ₹16 Cr₹11 Cr₹7.04 Cr₹5.25 Cr₹2.67 Cr
Earnings Per Share (Rs)₹0.66₹4.76₹2.92₹5.38₹2.80
PAT Margin (%)3.162.471.531.471.38
ROE(%)13.3310.7710.7620.0811.87
ROCE(%)14.4213.7515.2518.6713.01
Total Debt/Equity(x)1.340.940.341.031.32

Key Financials

Market Cap : ₹ 1,024.8 Cr
Revenue (TTM) : ₹ 703.1 Cr
Net Profit(TTM) : ₹ 23.4 Cr
EPS (TTM) : ₹ 0.9
P/E (TTM) : 43.8

Industry Peers & Returns1W1M1Y
SUDARSHAN PHARMA INDUSTRIES -2.2% 11% 34.4%
SUN PHARMACEUTICAL INDUSTRIES 0.8% 7.3% 15.6%
DIVIS LABORATORIES 1.9% 8.2% 6.2%
TORRENT PHARMACEUTICALS 0.6% 12.6% 43.9%
CIPLA 0.2% 6.3% -4.5%
DR REDDYS LABORATORIES -1.8% -3.5% -3.4%
MANKIND PHARMA 1.4% 6.7% -3.4%
LUPIN 0.4% 6.5% 29%
ZYDUS LIFESCIENCES 1.1% 6.7% 16.7%


SUDARSHAN PHARMA INDUSTRIES Revenues
[BOM: 543828]

Y-o-Y

8.95 %

5 Yr CAGR

27.13 %

Years Revenues % Change
Mar2025 ₹505 Cr
8.95
Mar2024 ₹464 Cr
0.48
Mar2023 ₹461 Cr
29.19
Mar2022 ₹357 Cr
84.69
Mar2021 ₹193 Cr -


SUDARSHAN PHARMA INDUSTRIES Operating Profit
[BOM: 543828]

Y-o-Y

75.00 %

5 Yr CAGR

53.64 %

Years Operating Profit % Change
Mar2025 ₹40 Cr
75.00
Mar2024 ₹23 Cr
55.30
Mar2023 ₹15 Cr
34.56
Mar2022 ₹11 Cr
52.37
Mar2021 ₹7.16 Cr -

Operating Margins
Y-o-Y

60.57 %

5 Yr CAGR

20.80 %

Years Operating Margin% % Change
Mar2025 7.9%
60.57
Mar2024 4.92%
54.72
Mar2023 3.18%
3.92
Mar2022 3.06%
-17.52
Mar2021 3.71% -

SUDARSHAN PHARMA INDUSTRIES Profit After Tax
[BOM: 543828]

Y-o-Y

39.28 %

5 Yr CAGR

56.32 %

Years Profit After Tax % Change
Mar2025 ₹16 Cr
39.28
Mar2024 ₹11 Cr
62.78
Mar2023 ₹7.04 Cr
34.09
Mar2022 ₹5.25 Cr
96.41
Mar2021 ₹2.67 Cr -

PAT Margins
Y-o-Y

27.94 %

5 Yr CAGR

23.01 %

Years PAT Margin(%) % Change
Mar2025 3.16 %
27.94
Mar2024 2.47 %
61.44
Mar2023 1.53 %
4.08
Mar2022 1.47 %
6.52
Mar2021 1.38 % -

SUDARSHAN PHARMA INDUSTRIES Earnings Per Share (EPS)
[BOM: 543828]

Y-o-Y

-86.13 %

5 Yr CAGR

-30.32 %

Years EPS % Change
Mar2025 ₹0.66
-86.13
Mar2024 ₹4.76
63.01
Mar2023 ₹2.92
-45.72
Mar2022 ₹5.38
92.14
Mar2021 ₹2.80 -

SUDARSHAN PHARMA INDUSTRIES Return on Capital Employed (ROCE)
[BOM: 543828]

Y-o-Y

4.87 %

5 Yr CAGR

2.61 %

Years ROCE % Change
Mar2025 14.42%
4.87
Mar2024 13.75%
-9.84
Mar2023 15.25%
-18.32
Mar2022 18.67%
43.50
Mar2021 13.01% -

SUDARSHAN PHARMA INDUSTRIES Share Price vs Sensex

Current Share Price : ₹41.0
Current MarketCap: ₹ 1,024.8 Cr
Updated EOD on :Jul 20,2026

Share Price Returns(%) 1 Week 1 Month 1 Year
SUDARSHAN PHARMA INDUSTRIES

-2.2%

11%

34.4%

SENSEX

0.1%

0.7%

-6.6%

SUDARSHAN PHARMA INDUSTRIES related INDICES

No BSE index found!
No NSE index found

You may also like the below Video Courses


FAQ about SUDARSHAN PHARMA INDUSTRIES Financials


How the annual revenues of SUDARSHAN PHARMA INDUSTRIES have changed ?

The Revenues of SUDARSHAN PHARMA INDUSTRIES have increased by 8.95% YoY .

How the Earnings per Share (EPS) of SUDARSHAN PHARMA INDUSTRIES have changed?

The Earnings Per Share (EPS) of SUDARSHAN PHARMA INDUSTRIES has decreased by -86.13 % YoY .